Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,460.00 JPY | -0.43% | -9.07% | -17.42% |
Jun. 12 | Samco's Nine-Month Profit Edges Higher as Net Sales Improve | MT |
Mar. 14 | Samco's Fiscal H1 Profit Improves on Higher Net Sales; Shares Down 5% | MT |
Fiscal Period: July | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.89 | 5.11 | 5.3 | 6.73 | 8.25 | |||||
Return on Total Capital | 2.28 | 6.09 | 6.3 | 8.14 | 10.14 | |||||
Return On Equity % | 2.6 | 7.43 | 8.3 | 10.81 | 12.89 | |||||
Return on Common Equity | 2.6 | 7.43 | 8.3 | 10.81 | 12.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 45.99 | 48.68 | 51.01 | 49.82 | 49.41 | |||||
SG&A Margin | 33.27 | 27.76 | 27.1 | 22.45 | 20.61 | |||||
EBITDA Margin % | 8.51 | 17.16 | 18.85 | 22.59 | 24.47 | |||||
EBITA Margin % | 6.64 | 15.37 | 17.21 | 21.42 | 23.74 | |||||
EBIT Margin % | 6.64 | 15.37 | 17.21 | 21.42 | 23.74 | |||||
Income From Continuing Operations Margin % | 4.36 | 10.8 | 13.14 | 16.43 | 17.45 | |||||
Net Income Margin % | 4.36 | 10.8 | 13.14 | 16.43 | 17.45 | |||||
Net Avail. For Common Margin % | 4.36 | 10.8 | 13.14 | 16.43 | 17.45 | |||||
Normalized Net Income Margin | 3.85 | 9.86 | 11.34 | 14.45 | 15.38 | |||||
Levered Free Cash Flow Margin | 15.46 | 12.74 | -7.97 | 16.06 | -3.8 | |||||
Unlevered Free Cash Flow Margin | 15.5 | 12.77 | -7.93 | 16.09 | -3.77 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.46 | 0.53 | 0.49 | 0.5 | 0.56 | |||||
Fixed Assets Turnover | 1.62 | 1.94 | 1.73 | 1.72 | 2.04 | |||||
Receivables Turnover (Average Receivables) | 2.8 | 3.99 | 3.26 | 5.09 | 7.02 | |||||
Inventory Turnover (Average Inventory) | 2.75 | 3.5 | 3.81 | 2.64 | 2.11 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.34 | 4.63 | 4.24 | 3.82 | 3.8 | |||||
Quick Ratio | 3.66 | 4.2 | 3.7 | 2.78 | 2.59 | |||||
Operating Cash Flow to Current Liabilities | 0.51 | 0.53 | 0.27 | 0.51 | -0.07 | |||||
Days Sales Outstanding (Average Receivables) | 130.29 | 91.7 | 111.8 | 71.73 | 51.98 | |||||
Days Outstanding Inventory (Average Inventory) | 132.6 | 104.68 | 95.82 | 138.35 | 173.01 | |||||
Average Days Payable Outstanding | 65.15 | 53.21 | 53.6 | 65.93 | 65.92 | |||||
Cash Conversion Cycle (Average Days) | 197.74 | 143.18 | 154.02 | 144.15 | 159.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 8.78 | 8.16 | 7.52 | 8.79 | 7.56 | |||||
Total Debt / Total Capital | 8.07 | 7.54 | 7 | 8.08 | 7.03 | |||||
LT Debt/Equity | 0.21 | 0.1 | 0.02 | 1.42 | 0.92 | |||||
Long-Term Debt / Total Capital | 0.19 | 0.09 | 0.02 | 1.31 | 0.86 | |||||
Total Liabilities / Total Assets | 23.22 | 22.06 | 22.03 | 24.84 | 24.68 | |||||
EBIT / Interest Expense | 109.33 | 300.67 | 329.67 | 457 | 464.75 | |||||
EBITDA / Interest Expense | 140 | 335.67 | 361 | 482 | 479 | |||||
(EBITDA - Capex) / Interest Expense | 117 | 321.33 | 101 | 404 | 474.5 | |||||
Total Debt / EBITDA | 1.73 | 0.71 | 0.65 | 0.61 | 0.44 | |||||
Net Debt / EBITDA | -9.71 | -4.57 | -3.8 | -3.42 | -2.33 | |||||
Total Debt / (EBITDA - Capex) | 2.07 | 0.74 | 2.34 | 0.73 | 0.44 | |||||
Net Debt / (EBITDA - Capex) | -11.62 | -4.78 | -13.59 | -4.08 | -2.35 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -9.7 | 18.9 | -2.1 | 11.4 | 22.32 | |||||
Gross Profit, 1 Yr. Growth % | -12.52 | 25.86 | 2.59 | 8.8 | 21.32 | |||||
EBITDA, 1 Yr. Growth % | -44.44 | 139.76 | 7.55 | 33.52 | 32.5 | |||||
EBITA, 1 Yr. Growth % |